Back to companies

Fulgent Genetics Inc (Fulgent) is a provider of clinically diagnostic genetic testing and genetic information to physicians. The company offers a range of testing options through its proprietary technology platform that integrates genetic diagnostics tools with adaptive learning software, data comparison and suppression algorithms, and laboratory processes. Its major offering include genes and panels, known mutation, genomic testing, hereditary cancer, carrier screening, tumor profiling, newborn genetics and covid-19 testing. It offers genetic tests for cardiovascular and pediatric diseases, neurological disorders, cancers, and primarily serves medical institutions, hospitals in the US, Canada and other countries. Fulgent is headquartered in Temple City, California, the US.

Headquarters United States of America

Address 4978 Santa Anita Ave Ste 205, Temple City, California, 91780-3600


Telephone 1 626 3500537

No of Employees 645

Industry Medical Equipment

Ticker Symbol & Exchange FLGT (NASD)

Revenue (2020) $992.6M 135.4% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX 136.7% (2020 vs 2019)

Market Cap* $1.2B

Net Profit Margin (2020) XXX 0.6% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Fulgent Genetics Inc

40+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Fulgent Genetics Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services
Genes and Panels Sequencing Services
Known Mutation
Genomic Testing
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Corporate Changes/Expansions In May, the company announced the opening of new state-of-the-art oncology laboratory in El Monte, California, the US.
2022 Acquisitions/Mergers/Takeovers In April, the company acquired the US-based Inform Diagnostics from Avista Capital Partners.
2022 Contracts/Agreements In March, the company, Illumina, InVitae, GeneDx, and PerkinElmer Genomics, formed the CardioGenomic Testing Alliance (CGTA), a collaborative group aimed at raising awareness and utilization of genomic testing in cardiology.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Fulgent Genetics Inc Myriad Genetics Inc Natera Inc InVitae Corp Ambry Genetics Corp
Headquarters United States of America United States of America United States of America United States of America United States of America
City Temple City Salt Lake City Austin San Francisco Aliso Viejo
State/Province California Utah Texas California California
No. of Employees 645 2,400 2,670 2,300 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Ming Hsieh Chief Executive Officer; Chairman; President Executive Board 2016 66
Paul Kim Chief Financial Officer Senior Management 2016 54
James Xie Chief Operating Officer Senior Management 2022 56
Lawrence Weiss, M.D. Chief Medical Officer Senior Management 2021 -
Han Lin Gao, M.D., Ph.D. Chief Scientific Officer; Lab Director Senior Management 2016 55
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer